Filing Details

Accession Number:
0001209191-16-115635
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-26 12:08:05
Reporting Period:
2015-02-04
Filing Date:
2016-04-26
Accepted Time:
2016-04-26 12:08:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1337553 Aerie Pharmaceuticals Inc AERI Biological Products, (No Disgnostic Substances) (2836) 203109565
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1589991 D. Gerald Cagle C/O Aerie Pharmaceuticals, Inc.,
2030 Main Street, Suite 1500
Irvine CA 92614
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-04 500 $25.60 4,054 No 4 P Direct
Common Stock Acquisiton 2015-02-05 500 $24.54 4,554 No 4 P Direct
Common Stock Acquisiton 2015-08-10 100 $16.31 4,654 No 4 P Direct
Common Stock Acquisiton 2015-08-10 100 $16.35 4,754 No 4 P Direct
Common Stock Acquisiton 2015-08-10 100 $16.35 4,854 No 4 P Direct
Common Stock Acquisiton 2015-08-10 846 $16.39 5,700 No 4 P Direct
Common Stock Acquisiton 2015-08-12 500 $15.46 6,200 No 4 P Direct
Common Stock Acquisiton 2015-08-28 1,524 $16.60 7,724 No 4 P Direct
Common Stock Acquisiton 2015-08-28 476 $16.60 8,200 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct